Cargando…

Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis

Background: The risk of falls and bone fractures with sodium-glucose co-transporter-2 (SGLT2) inhibitors has been characterized by conflicting evidence. Therefore, we decided to investigate the reporting probability of falls and fractures by comparing SGLT2 inhibitors with DPP4 inhibitors. Methods A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mascolo, Annamaria, Rafaniello, Concetta, di Mauro, Gabriella, Ruggiero, Donatella, Campitiello, Maria Rosaria, Donniacuo, Maria, Berrino, Pasquale Maria, Rossi, Francesco, Paolisso, Giuseppe, Capuano, Annalisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657831/ https://www.ncbi.nlm.nih.gov/pubmed/38027019 http://dx.doi.org/10.3389/fphar.2023.1245642

Ejemplares similares

COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database
por: Ruggiero, Rosanna, et al.
Publicado: (2023)

Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System
por: Scavone, Cristina, et al.
Publicado: (2020)

Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance
por: Ruggiero, Rosanna, et al.
Publicado: (2022)

Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review
por: Mascolo, Annamaria, et al.
Publicado: (2020)

The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study
por: di Mauro, Gabriella, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database
por: Ruggiero, Rosanna, et al.
Publicado: (2020)

Pillars and Pitfalls of the New Pharmacovigilance Legislation: Consequences for the Identification of Adverse Drug Reactions Deriving From Abuse, Misuse, Overdose, Occupational Exposure, and Medication Errors
por: Sessa, Maurizio, et al.
Publicado: (2018)

Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors
por: Scisciola, Lucia, et al.
Publicado: (2023)

Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis
por: Capuano, Annalisa, et al.
Publicado: (2022)

COVID-19 and atrial fibrillation: Intercepting lines
por: Donniacuo, Maria, et al.
Publicado: (2023)

Preventable Cases of Oral Anticoagulant-Induced Bleeding: Data From the Spontaneous Reporting System
por: Mascolo, Annamaria, et al.
Publicado: (2019)

Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
por: Mascolo, Annamaria, et al.
Publicado: (2022)

Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study
por: Zinzi, Alessia, et al.
Publicado: (2023)

The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
por: Mascolo, Annamaria, et al.
Publicado: (2021)

Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study
por: Scavone, Cristina, et al.
Publicado: (2017)

Therapeutic strategies to fight COVID‐19: Which is the status artis?
por: Scavone, Cristina, et al.
Publicado: (2021)

A Pharmacovigilance Study on the Safety of Axicabtagene Ciloleucel Based on Spontaneous Reports from the EudraVigilance Database
por: Rafaniello, Concetta, et al.
Publicado: (2023)

Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions
por: Sessa, Maurizio, et al.
Publicado: (2017)

The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome
por: Cherney, David, et al.
Publicado: (2017)

Tisagenlecleucel in Children and Young Adults: Reverse Translational Research by Using Real-World Safety Data
por: Rafaniello, Concetta, et al.
Publicado: (2020)

Did the New Italian Law on Mandatory Vaccines Affect Adverse Event Following Immunization’s Reporting? A Pharmacovigilance Study in Southern Italy
por: Scavone, Cristina, et al.
Publicado: (2018)

Hypoglycemia, polycythemia and hyponatremia in a newborn exposed to nebivolol during pregnancy
por: Sullo, Maria Giuseppa, et al.
Publicado: (2015)

PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database
por: di Mauro, Gabriella, et al.
Publicado: (2020)

The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs
por: Scavone, Cristina, et al.
Publicado: (2019)

SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment
por: di Mauro, Gabriella, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance
por: Mascolo, Annamaria, et al.
Publicado: (2021)

Did the COVID-19 Pandemic Affect Contrast Media-Induced Adverse Drug Reaction’s Reporting? A Pharmacovigilance Study in Southern Italy
por: Rossi, Claudia, et al.
Publicado: (2022)

Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician’s Guide
por: Simes, Bryce C, et al.
Publicado: (2019)

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Benefits Versus Risk
por: Jasleen, Bains, et al.
Publicado: (2023)

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Harms or Unexpected Benefits?
por: Andreea, Munteanu Madalina, et al.
Publicado: (2023)

Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy
por: Scavone, Cristina, et al.
Publicado: (2019)

Current pharmacological treatments for COVID‐19: What's next?
por: Scavone, Cristina, et al.
Publicado: (2020)

Effects of Sildenafil on the Gastrocnemius and Cardiac Muscles of Rats in a Model of Prolonged Moderate Exercise Training
por: Rinaldi, Barbara, et al.
Publicado: (2013)

Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors: Benefits in Diabetics With Cardiovascular Disease
por: Aftab, Saba, et al.
Publicado: (2020)

Sodium-glucose cotransporter 2 (SGLT2) inhibitor initiation and hepatocellular carcinoma prognosis
por: Hendryx, Michael, et al.
Publicado: (2022)

Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Heart Failure: An Umbrella Review
por: Roy, Raj, et al.
Publicado: (2023)

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors and CKD: Are You a #Flozinator?
por: Krishnan, Anoushka, et al.
Publicado: (2023)

The efficacy and the safety of eltrombopag in pediatric patients with severe aplastic anemia: a systematic review
por: Marrapodi, Maria Maddalena, et al.
Publicado: (2023)

Pharmacovigilance in Italy: An overview
por: Mazzitello, Carmela, et al.
Publicado: (2013)

Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study
por: Sessa, Maurizio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0jjtbdiv4pmr1ul24he6ganr5g